Immuron (IMRN) Shares Outstanding (2015 - 2026)
Immuron (IMRN) posted Shares Outstanding (Entity) of $5.8 million for Q2 2025, up 2.61% on a QoQ basis from $5.7 million in Q2 2024, and up 2.61% year-over-year from $5.7 million in Q2 2024.
Analysis
Immuron (IMRN) Shares Outstanding (2015 - 2026) Analysis & Trends
Immuron has reported Shares Outstanding (Entity) for 11 years, with the latest figure at $5.8 million in Q2 2025.
- On a quarterly basis, Shares Outstanding (Entity) rose 2.61% year-over-year to $5.8 million in Q2 2025; TTM through Jun 2025 was $5.8 million, a 2.61% increase from a year earlier, with the FY2025 full-year figure at $5.8 million, up 2.61% from the prior year.
- Shares Outstanding (Entity) was $5.8 million for Q2 2025 at Immuron, up from $5.7 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $5.8 million in Q2 2025, with the low at $5.7 million in Q2 2021.
- Average Shares Outstanding (Entity) over 5 years is $5.7 million, with a median of $5.7 million recorded in 2022.
- The sharpest annual moves came in 2021 and 2023: Shares Outstanding (Entity) grew 27.47% in 2021, then changed 0.0% in 2023.
- Over 5 years, Shares Outstanding (Entity) stood at $5.7 million in 2021, then grew by 0.24% to $5.7 million in 2022, then changed by 0.0% to $5.7 million in 2023, then gained by 0.09% to $5.7 million in 2024, then grew by 2.61% to $5.8 million in 2025.
- The last three Shares Outstanding (Entity) figures came in at $5.8 million (Q2 2025), $5.7 million (Q2 2024), and $5.7 million (Q2 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 540.00 Mn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 253.70 Mn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 102.80 Mn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 61.30 Mn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 398.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 133.61 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 147.70 Mn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Immuron | 10.53 Mn | 1.51 Mn | - | 5.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 28, 2026 | 5.77 Mn |
| Dec 31, 2025 | 5.77 Mn |
| Sep 2, 2025 | 5.77 Mn |
| Jun 30, 2025 | 5.77 Mn |
| Dec 31, 2024 | 5.70 Mn |
| Sep 9, 2024 | 5.70 Mn |
| Jun 30, 2024 | 5.70 Mn |
| Dec 31, 2023 | 5.69 Mn |
| Sep 28, 2023 | 5.69 Mn |
| Aug 30, 2023 | 5.69 Mn |
| Jun 30, 2023 | 5.69 Mn |
| Dec 31, 2022 | 5.69 Mn |
| Aug 31, 2022 | 5.69 Mn |
| Jun 30, 2022 | 5.69 Mn |
| Dec 31, 2021 | 5.53 Mn |
| Sep 30, 2021 | 5.53 Mn |
| Jun 30, 2021 | 5.53 Mn |
| Dec 31, 2020 | 4.41 Mn |
| Sep 1, 2020 | 4.41 Mn |
| Jun 30, 2020 | 4.41 Mn |